Trinity Bio ADR (TRIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,138 | 1,341 | 1,546 | 4,066 | 5,167 |
| Receivables | 11,480 | 14,488 | 10,893 | 10,614 | 16,065 |
| Inventories | 18,828 | 19,158 | 20,129 | 20,271 | 19,374 |
| Other current assets | 456 | 528 | 431 | 566 | 518 |
| TOTAL | $35,902 | $35,515 | $32,999 | $35,517 | $41,124 |
| Non-Current Assets | |||||
| PPE Net | 5,302 | 4,011 | 4,309 | 4,382 | 4,621 |
| Investments And Advances | 249 | 35 | 67 | 115 | 166 |
| Intangibles | 56,987 | 57,813 | 55,919 | 53,656 | 51,343 |
| Other Non-Current Assets | 6,725 | 6,338 | 6,337 | 6,118 | 6,036 |
| TOTAL | $69,263 | $68,197 | $66,632 | $64,271 | $62,166 |
| Total Assets | $105,165 | $103,712 | $99,631 | $99,788 | $103,290 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 108,015 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 29,703 | 30,355 | 26,486 | 25,287 | 26,782 |
| Other current liabilities | 693 | 1,797 | 2,531 | 2,743 | 2,818 |
| TOTAL | $141,209 | $34,494 | $31,523 | $30,466 | $32,095 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 88,686 | 83,643 | 79,607 | 72,391 |
| Other Non-Current Liabilities | 20,431 | 20,604 | 18,887 | 18,487 | 18,947 |
| TOTAL | $35,938 | $123,933 | $117,646 | $112,947 | $106,376 |
| Total Liabilities | $177,147 | $158,427 | $149,169 | $143,413 | $138,471 |
| Shareholders' Equity | |||||
| Common Shares | 40 | 40 | 4,337 | 4,337 | 4,190 |
| Retained earnings | -116,169 | -98,727 | -93,656 | -87,783 | -79,117 |
| Other shareholders' equity | 5,347 | 5,127 | 984 | 1,024 | 1,349 |
| TOTAL | $-71,982 | $-54,715 | $-49,538 | $-43,625 | $-35,181 |
| Total Liabilities And Equity | $105,165 | $103,712 | $99,631 | $99,788 | $103,290 |